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This study investigated the transmission characteristics of carbapenem-resistant
Enterobacteriaceae (CRE) strains collected from a hospital setting in China, in which
consistent emergence of CRE strains were observable during the period of May
2013 to February 2014. Among the 45 CRE isolates tested, 21 (47%) strains were
found to harbor the blaNDM−1 element, and the rest of 24 CRE strains were all
positive for blaKPC−2. The 21 blaNDM−1—borne strains were found to comprise multiple
Enterobacteriaceae species including nine Enterobacter cloacae, three Escherichia coli,
three Citrobacter freundii, two Klebsiella pneumoniae, two Klebsiella oxytoca, and two
Morganella morganii strains, indicating that cross-species transmission of blaNDM−1 is a
common event. Genetic analyses by PFGE and MLST showed that, with the exception
of E. coli and E. cloacae, strains belonging to the same species were often genetically
unrelated. In addition to blaNDM−1, several CRE strains were also found to harbor the
blaKPC−2, blaVIM−1,and blaIMP−4 elements. Conjugations experiments confirmed that the
majority of carbapenem resistance determinants were transferable. Taken together, our
findings suggest that transmission of mobile resistance elements among members of
Enterobacteriaceae and clonal spread of CRE strains may contribute synergistically to a
rapid increase in the population of CRE in clinical settings, prompting a need to implement
more rigorous infection control measures to arrest such vicious transmission cycle in
CRE-prevalent areas.
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Introduction
β-Lactams have been a cornerstone in treatment of infections
caused by Gram-negative bacterial pathogens due to their high
efficacy and low toxicity to humans, among which carbapenems
are considered agents of the last resort, especially in cases
where extended-spectrum β-Lactamase (ESBL) producing
organisms were involved (Dalhoff and Thomson, 2003).
In the past two decades, usage of carbapenems such as
imipenem and meropenem has been substantially increased
due to the emergence of multidrug-resistant organisms (Goel
et al., 2011; Zilberberg and Shorr, 2013). However, increased
carbapenem consumption in turn initiated a vicious cycle
in which carbapenem-resistant Gram-negative pathogens
(CRGNP), which often cause untreatable hospital infections
(Livermore, 2004, 2009; Karaiskos and Giamarellou, 2014),
further gained selection advantage. Species belonging to the
family Enterobacteriaceae are common human pathogens which
can cause a wide range of community-acquired and nosocomial
infections (Stock, 2014). The emergence of carbapenem-resistant
Enterobacteriaceae (CRE) has posed a huge challenge to clinical
infection control. Carbapenem resistance in CRE was mainly
mediated by the production of carbapenemases, among which
KPC, Metallo-β-lactamases (VIM, IMP, NDM) and OXA-48 type
of enzymes were the most common (Nordmann et al., 2011).
New Delhi Metallo-β-lactamase-1 (NDM-1) was one of the
most important carbapenemases of CRE. Since its first discovery
in 2008 in a Klebsiella pneumoniae isolate recovered from a
patient at a hospital in New Delhi, India, it has been transmitted
to many species of Enterobacteriaceae in various countries
(Yong et al., 2009). NDM-1 is most frequently identified in the
Indian subcontinent, followed by the Balkans region and the
Middle East, and is mainly associated with community-acquired
infections.
In China, the first clinical report of blaNDM−1 involved
carbapenem-resistantAcinetobacter baumannii strains detectable
in four patients indifferent provinces in 2011 (Chen et al.,
2011). Since then it has been recoverable in most species of
Enterobacteriaceae, including K. pneumoniae, Klebsiella oxytoca,
Escherichia coli, Enterobacter cloacae, Enterobacter aerogenes,
and Citrobacter freundii. To date, NDM-1-producing isolates
have been reported in various cities in China including Beijing,
Changsha, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hebei,
Hong Kong, and Zhengzhou (Berrazeg et al., 2014; Qin et al.,
2014). Although various blaNDM−1-carrying CRE strains have
been sporadically identified, few outbreaks of CRE carrying the
blaNDM−1 element have been reported in China, suggesting that
the transmission of NDM-1 is mainly mediated by conjugative
plasmids, which is consistent with the features of NDM-
1 transmission observable in other parts of the world (Hu
et al., 2014). In this study, we report an increasing prevalence
of blaNDM−1-positive Enterobacteriaceae in a Jiaxing hospital,
which is located in Zhejiang Province, China. Through time-
series analysis of the molecular features and epidemiological
linkage of CRE recovered within the hospital, we demonstrated
that emergence of new CRE strains was due to a combination of
clonal spread of existing blaNDM−1-carrying strains and efficient
horizontal transfer of the blaNDM−1 elements from such strains
to other drug sensitive organisms. This combinatorial mode of
transmission of both CRE organisms and the resistance elements
that they harbor can theoretically result in an exponentially
increasing rate of spread of NDMpositive CRE in clinical settings
if proper infection control measures are not implemented to
disrupt the transmission routes.
Materials and Methods
Bacterial Strains and Species Identification
From May 2013 to February 2014, a total of 6598 clinical
Enteroabcteriaceae strains were isolated from different specimens
(urine, feces, and sputum) collected from patients in Second
People’s Hospital of Jiaxingin Zhejiang Province, China. All
isolates were identified using the Vitek 2 system (bioMérieux,
Marcy-l’E’ toile, France), and confirmed by the MALDI-TOF
MS apparatus (Bruker Microflex LT, Bruker Daltonik GmbH,
Bremen, Germany). These isolates were screened for their ability
to produce carbapenemases by a disc diffusion test, in which 10-
mg imipenem discs were used (Oxoid, Basingstoke, UK) (Zhou
et al., 2015). A total of 45 CRE isolates were recovered from these
Enterobacteriaceae strains.
Molecular Detection of Resistance Genes
PCR and nucleotide sequencing were employed to screen for the
presence of carbapenemase-encoding genes, including blaVIM,
blaIMP, blaKPC, blaOXA−48 and blaNDM−1, as well as ESBL genes,
including blaCTX−M, blaTEM and blaSHV, as described previously
(Dallenne et al., 2010). An imipenem-EDTA double-disc synergy
test and a modified Hodge test were used to screen for the
presence of Metallo-β-lactamases(MBLs) and carbapenemases,
respectively, and were analyzed according to CLSI guidelines
(Zhou et al., 2015).
Antimicrobial Susceptibility Testing
The MICs of 10 antibiotics, including imipenem, meropenem,
ceftazidime, cefotaxime, aztreonam, piperacillin-tazobactam,
fosfomycin, amoxicillin-clavulanic acid, amikacin, tigecycline,
were determined using the agar dilution method, and the results
were analyzed according to the CLSI criteria of 2014 (Zhou et al.,
2015). The 2014 EUCAST breakpoints were used (available at
http://www.eucast.org/clinical_breakpoints/) for tigecycline.
PFGE and MLST
Clonal relationships between blaNDM−1-positive isolates were
investigated by PFGE of XbaI-digested genomic DNA using
a Rotaphor System 6.0 instrument (Whatman Biometra,
Goettingen, Germany), with a running time of 24 h and pulse
times of 3–40 s. Salmonella strain H9812 was used as the control
strain. Bands were stained with ethidium bromide (0.5µg/mL)
prior to visualization under UV light. A dendrogram depicting
the genetic relatedness of the test strains was generated from
the homology matrix with a 0.2% coefficient by the unweighted
pair-group method, and by using arithmetic averages (UPGMA),
to describe the relationships of the PFGE profiles. Isolates were
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allocated to the same PFGE group if their dice similarity index
was ≥85%.
MLST was performed using seven housekeeping genes
inblaNDM−1-producing E. coli, K. pneumonia and E. cloacae
isolates, which were amplified using primers listed in the
online databases (http://pubmlst.org/ecloacae/ for E. cloacae,
http://bigsdb.web.pasteur.fr/klebsiella/klebsiella.html for K.
pneumoniae and http://mlst.warwick.ac.uk/mlst/dbs/Ecoli for E.
coli). The resultant PCR products were purified and sequenced.
Sequence types (STs) were assigned using online database tools.
Conjugation Experiments
The conjugation experiment was carried out using the mixed
broth method as previously described (Borgia et al., 2012).
Both the donor (blaNDM−1-positive Enterobacteriaceae) and the
recipient strains (sodium azide-resistant E. coli J53) were mixed
on Luria-Bertani agar at a ratio of 1:1, and the mixtures
were incubated for 24 h at 35◦C. Transconjugants were selected
on LB agar supplemented with sodium azide (100mg/L) and
meropenem (0.3mg/L). Colonies that grew on the selective
medium were picked for identification by the Vitek MS
system. Transformants that harbored blaNDM−1 and exhibited
resistance to carbapenems and cephalosporins were defined as
transconjugants.
Results
The study period and venue were May 2013 to February 2014
and the Second Hospital of Jiaxing, Zhejian Province, China,
respectively. During this period, a total of 45 CRE isolates
were recovered from 6598 clinical specimens (urine, feces and
sputum), among which 21 (47%) were found to harbor the
blaNDM−1 elements; the rest of 24 CRE strains were all positive
for blaKPC−2. The objective of the study was to investigate the
molecular events that lead to emergence of CRE in the hospital,
with a focus on understanding themolecular and epidemiological
features of transmission of both blaNDM−1-borne strains and
the blaNDM−1 element itself. The 21blaNDM−1−borne CRE
strains were found to comprise a variety of different species
of Enterobacteriaceae including nine E. cloacae, three E. coli,
three C. freundii, two K. pneumoniae, two K. oxytoca and two
M. morganii strains, indicating that blaNDM−1can be efficiently
acquired by various Enterobacteriaceae species. Most of these
blaNDM−1–borne CRE were recovered from patients in the
Neurosurgery Department (43%),who were subjected to various
neuronal system surgical procedures, followed by patients
from the Respiratory Department (19%) suffering mainly from
pulmonary infection, patients from the Pediatric Department
and Recovery department (14% each), and one patient each from
the Cardio-Thoracic Surgery and Breast Department (Table 1).
These blaNDM−1 borne CRE strains were isolated from urine
(85%), sputum (10%), and breast secretion (5%), respectively.
Clinical records showed that most of patients from whom
blaNDM−1–borne CRE were recovered have been subjected
to different types of antimicrobial treatment including the
use of cephalosporins (ceftazidime, cefoperazone/sulbactam,
cefuroxime, piperacillin/tazobactam), amikacin, levofloxacin and
tigecycline, and the vast majority of patients recovered and
were discharged from the hospital. Our record also showed
that although blaNDM−1-borne CRE were resistant to all
cephalosporins, clinical treatment with cephalosporins for non-
blood infections caused by blaNDM−1borne CRE remained
effective (Table 1). In addition, levofloxacin could be a choice for
treatment of infections caused by fluoroquinolone-susceptible
CREs. Likewise, amikacin was also a good choice since most of
the CRE were susceptible to this antibiotic.
The first case of CRE infection occurred in the Neurosurgery
Department on June 24, 2013, with the causative organism
being identified as K. oxytoca, recurrent infection due to the
same clone with identical PFGE pattern occurred on August
15, 2013, suggesting the long-term persistence of similar clones
in a hospital. Interestingly, non-clonal spread was seen in
specific species of CRE such as C. freundii and K. pneumoniae.
For instance, the first case of NDM-producing C. freundii
infection was recorded on June 26, 2014 in the Neurosurgery
Department, followed by the second case in the Respiratory
Department on August 17, 2013; the third case was recorded back
in Neurosurgery Department on February 20, 2014, however,
pneumonia-associated C. freundii strains recoverable form each
of these three cases were found to be genetically non-identical
(Figure 1, Table 1). Likewise, two genetically un-related strains
of K. pneumoniae were found to cause infections in different
departments at different dates (Figure 1,Table 1). On the other
hand, both non-clonal and clonal spread could be seen upon
analysis of infection caused by E. coli and E. cloacae. The first
case of NDM-producing E. coli was observable in the Pediatric
Department on September 26, 2013, whereas a different strain
was found to cause infections in the Recovery Department in
2014. Although the NDM-1 producing E. coli strains recovered
belonged to two different clones, three of the strains were
found to belong to ST167 (Figure 1, Table 1). E. cloacae were
the most common CRE species in this hospital. The first case
of E. cloacae was reported on June 29, 2013 in the Pediatric
Department. The same clone, which belonged to ST114, was
causing an outbreak in the Neurosurgery Department, in which
four infections recorded during the period of August to October,
2013. In August 2013, infections caused by a different clone
also occurred in the Pediatric Department, and other clones
were also found to cause infections in different departments at
different times. These clones belonged to different ST types such
as ST93, ST190, and ST66 (Figure 1, Table 1). Finally, NDM-1
producing Morganella morganii was reported for the first time
in this hospital. Two very similar clones were found to cause
infections in different departments and dates (Figure 1, Table 1).
Antimicrobial susceptibilities were performed on all CRE
strains. All 21blaNDM−1-positive isolates were resistant tomost β-
lactam antibiotics, including expanded-spectrum cephalosporins
and the carbapenems. Moreover, all isolates were resistant
to fosfomycin (≥256mg/L) and amoxicillin-clavulanic acid
(Table 2). In addition, 10 isolates were resistant to amikacin
(≥64 mg/L). Only two isolates were sensitive to aztreonam
(≤4mg/L). Sixteen isolates exhibited intermediate susceptibility
to tigecycline (MICs≤ 1 mg/L), and 11 were tigecycline-resistant
(MICs > 2 mg/L). The high frequency of resistance observed to
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TABLE 1 | Origin and molecular features of Enterobacteriaceae isolates harboring blaNDM−1, and clinical outcome of diseases that they caused.
Isolate Isolation Location of Culture Diseases Treatment Outcome PFGE MLST
date acquisition type
EC-06 26/9/2013 PD Urine Neonatal pneumonia Ceftazidime Recovered Ec1 ST167
EC-33 18/01/2014 ECD Urine Myelitis NT Uracratia Ec2 ST167
EC-34 12/02/2014 RCD Urine Myelitis, Urinary tract
infection
NR NR Ec2 ST167
KO-03 24/06/2013 ND Urine Subarachnoid
hemorrhage,Oculomotor
paralysis, Pneumonia
NR Recovered Ko1 ND
KO-16 15/08/2013 ND Urine Cerebroma recurrence NT Discharged Ko1 ND
CF-05 26/06/2013 ND Urine Traumatic
subarachnoid
hemorrhage
Levofloxacin, Amikacin Recovered Cf1 ND
CF-17 20/08/2013 RD Sputum Pulmonary infection Tigecycline Recovered Cf2 ND
CF-35 20/02/2013 ND Urine Cerebral contusion Levofloxacin Recovered Cf3 ND
ECL-07 29/06/2013 PD Urine Neonatal pneumonia Ceftazidime Recovered Ecl1 ST114
ECL-08 05/08/2013 ND Urine Cerebral hemorrhage Levofloxacin Transferred Ecl1 ST114
ECL-09 07/08/2013 ND Urine Intracranial aneurysm Piperacillin/Tazobactam Discharged Ecl2a ST93
ECL-10 09/08/2013 ND Urine Traumatic subdural
hemorrhage
Levofloxacin Recovered Ecl1 ST114
ECL-18 28/08/2013 PD Urine Neonatal infections Ceftazidime Recovered Ecl3 ST190
ECL-19 28/08/2013 RD Urine Pulmonary infection Mupirocin ointment Ecl1 ST114
ECL-22 02/10/2013 ND Urine Subarachnoid
hemorrhage
Levofloxacin Recovered Ecl1 ST114
ECL-27 11/11/2013 CTS Sputum Abdominal aortic
aneurysm
Cefuroxime Recovered Ecl4 ST66
ECL-28 27/11/2013 RD Urine Chronic obstructive
bronchitis
Cefoperazone/Sulbactam Ecl2b ST93
KP-04 26/06/2013 RD Urine Bladder
neoplasmpulmonary
infection
Ceftazidime, Piperacillin/Tazobactam Discharged Kp1 ST147
KP-14 08/08/2013 ND Urine Cerebral hernia Levofloxacin Discharged Kp2 ST1724
MM-23 04/10/2013 BD Secretion Cholangitis Amikacin, Metronidazole Recovered Mm1a ND
MM-26 29/10/2013 RCD Urine Spinal cord injury Amikacin Recovered Mm1b ND
EC, Escherichia coli; KO, Klebsiella oxytoca; CF, Citrobacter freundii; ECL, Enterobacter cloacae; KP, Klebsiella pneumoniae; MM, Morganella morganii. JH, the Second People’s Hospital
of JiaXing; NT, not treated; NR, no record; ND, not determined. PD, Pediatric Department; RCD, Recovery Department; ND, Neurosurgery Department; CTS, Cardio-Thoracic Surgery;
RD, Respiratory Department; BD, Breast Department.
alternative therapeutic antibiotics is a great concern for clinicians
in charge of treating infections caused by these CREs.
Transferability of resistance determinants in these CRE
strains, in particular those producing NDM-1, was investigated.
Conjugation experiments were successful for all isolates
except for two (ECL-8 and CF-17) blaNDM−1-positive isolates.
The resulting 19 transconjugants all exhibited resistance to
carbapenems and cephalosporins. Importantly, fosfomycin and
amikacin resistance determinants could also be transferred
to the recipient E. coli strain (Table 2). Phenotypic resistance
to all β-lactams in these isolates suggested that they might
express additional β-lactamases since NDM-1 would not mediate
resistance to aztreonam. In view of the discrepancy between
the existence of known carbapenemase genes and the drug
susceptibility profiles of the test strains, all CRE strains and
their corresponding transconjugants were screened for the
presence of additional β-lactamase genes. Our data revealed
that in addition to blaNDM−1, strains CF35, ECL19, and KP14
also harbored blaKPC−2, strain KP04 was found to harbor
blaVIM−1,and blaIMP−4 was detectable in ECL18. To the best of
our knowledge, this is the first case of K. pneumoniae containing
both blaNDM−1 and blaVIM−1, hence further works are required
to elucidate the mechanisms governing the uptake of multiple
carbapenemase genes in a single organism. In addition, 18 out
of the 21 (86%) blaNDM−1-positive isolates were found to harbor
ESBL genes in various combinations (Table 2). It should also be
noted that the additional resistance genes detectable in several
isolates, including blaSHV−12, blaCTX−M−3/14, blaTEM−1 and
blaKPC−2,could be co-transferred to the E. coli recipient strain
J53, along with the blaNDM−1 element (Table 2).
Discussion
Since the first report of their emergence, NDM-1-producing
Enterobacteriaceae have become a worldwide public health
concern (Patel and Bonomo, 2013). In China, currently available
data tend to suggest that blaNDM−1 is only present at a
relatively low frequency and spreading sporadically amongst
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FIGURE 1 | Timeline of events in which epidemiologically linked
NDM-1–producing Enterobacteriaceae strains were recovered. Test
strains were isolated from May2013 to February 2014 in the Second
People’s Hospital of Jiaxing. Dates are shown as date/month.
Abbreviations: △, NDM-1 positive isolate; EC, Escherichia coli; KO,
Klebsiella oxytoca; CF, Citrobacter freundii; ECL, Enterobacter cloacae;
KP, Klebsiella pneumoniae MM, Morganella morganii. PD, Pediatric
Department; RCD, Recovery Department; ND, Neurosurgery Department;
CTS, Cardio-Thoracic Surgery; RD, Respiratory Department; BD, Breast
Department.
Enterobacteriaceae (Wang et al., 2013; Hu et al., 2014). A
recent study reported a high rate [33.3% (16/48)] of NDM-
1 positive CRE organisms in a hospital in Henan Province,
China, most of which were due to plasmidmediated transmission
of the blaNDM−1 elements among different members of
Enterobacteriaceae (Qin et al., 2014). Although the prevalence of
blaNDM−1-positive CRE has been increasing over the past several
years in China, very few epidemiological data are available to
elucidate the underlying mechanisms that mediate the increased
rate of transmission of NDM-1 positive CRE strains in hospitals.
In this study, we identified 21 NDM-1-producing strains of
Enterobacteriaceae in a hospital over a short period of time, from
May 2013 to February 2014, with the majority of the strains
(18/21) being collected during the period of June–November
2013. Our data suggest that a combination of outbreak of
CRE infections and sporadic emergence of genetically unrelated
resistant organisms contributed to the dramatic increase of CRE
infections in this hospital during this period, prompting a need
to investigate the molecular basis of these events. It should be
noted that the series of CRE infections investigated in this study
represents the most serious of its kind in China to date (Berrazeg
et al., 2014; Zhou et al., 2014).
MLST-diverse NDM-1-producing E. coli (ST410, ST131,
ST684, and ST101) and K. pneumoniae strains (ST147, ST14,
ST11, and ST340) have been identified worldwide (Poirel et al.,
2011). In this work, the NDM-1 positive E. coli strains tested
were found to belong to ST167 with two distinct PFGE types.
NDM-1 positive ST167 E. coli were previously shown to be an
animal-associated clone recoverable in both France and China
(Cuzon et al., 2013; Zhang et al., 2013; Yang et al., 2014).
Repeated emergence of these NDM-1 positive E. coli strains in
China represents a significant clinical and public health concern.
The two K. pneumoniae isolates reported in the current study
belonged to ST147 and a novel type, ST1724. Clinical NDM-1-
producing K. pneumoniae ST147 strains are frequently detected
worldwide, suggesting that they play an important role in the
dissemination of the blaNDM−1 elements to other K. pneumoniae
strains (Giske et al., 2012; Peirano et al., 2014). Identification
of carbapenem-resistant K. pneumoniae strains belonging to the
novel STs (ST359 and ST1724) in this study infers that the size of
the existing pool of NDM-1-producing strains has been further
expanded.
In contrast to E. coli and K. pneumoniae, MLST type of
NDM-1-producing E. cloacae strains in this study included both
epidemic ST types and new ST types. A carbapenem-resistant
E. cloacae strain belonging to ST89 and producing the OXA-48
carbapenemase was isolated in Poland in 2014 (Majewski et al.,
2014). Izdebski et al. reported that the ST66, ST78, and ST114
types have spread worldwide and were commonly associated with
production of ESBLs and carbapenemases in many countries
(Izdebski et al., 2014). NDM positive E. cloacae strains are among
the most frequently reported CRE species and are known to
cause occasional hospital outbreaks and community-acquired
infections (Rozales et al., 2014; Yanik et al., 2014; Stoesser et al.,
2015). In this study, we reported a similar situation in which E.
cloacae belonging to the ST114 type was linked to five infection
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TABLE 2 | Profiles of antimicrobial drug susceptibility and detectable-lactamase determinants of NDM-1 positive CRE strains and the corresponding
transconjugants.
Strains MICs (mg/L) Additional β lactamase determinants
IPM MEM CAZ CTX ATM TZP SCF AMC LEV FOS AK TIG
EC-06 16 32 >256 >256 >256 >256 >256 128 8 32 4 2 CTX-M-3, CTX-M-14,SHV-12
T-EC06 16 32 >256 >256 2 >256 >256 128 <0.125 1 1 –
EC-33 4 4 >256 >256 >256 >256 >256 64 32 32 2 1 CTX-M-15
T-EC33 4 4 >256 >256 >256 >256 >256 64 <0.125 1 1 CTX-M-15
EC-34 4 8 >256 >256 >256 >256 >256 128 32 32 2 2 CTX-M-15, TEM-1,SHV-12
T-EC34 4 4 >256 >256 >256 >256 >256 64 <0.125 1 1 TEM-1,SHV-12
KO-03 8 16 >256 >256 >256 >256 >256 128 16 16 1 4 SHV-12
T-KO03 16 32 >256 >256 2 >256 >256 128 <0.125 1 1 –
KO-16 8 16 256 >256 >256 >256 >256 128 16 16 1 4 SHV-12
T-KO16 16 32 >256 >256 >256 >256 >256 128 <0.125 1 1 SHV-12
CF-05 16 32 >256 >256 >256 >256 >256 256 4 8 1 2 SHV-12
T-CF05 16 32 >256 >256 >256 >256 >256 128 <0.125 1 1 SHV-12
CF-17 8 8 >256 >256 256 >256 >256 256 8 32 16 2 SHV-12
CF-35 8 32 >256 >256 >256 >256 >256 >256 8 16 >64 1 CTX-M-3, KPC-2,SHV-12
T-CF35 2 1 16 8 128 128 32 128 <0.125 0.25 >64 0.5 SHV-12
ECL-07 4 16 >256 >256 >256 >256 >256 256 16 64 >64 2 CTX-M-14, TEM-1,SHV-12
T-ECL07 4 2 >256 128 64 256 128 256 <0.125 0.5 1 1 TEM-1
ECL-08 4 4 >256 >256 >256 >256 >256 128 16 64 >64 4 CTX-M-14,TEM-1,SHV-12
ECL-09 4 16 >256 >256 >256 >256 >256 256 32 32 >64 4 CTX-M-3, CTX-M-14, TEM-1,SHV-12
T-ECL09 4 1 >256 256 32 256 256 256 0.25 0.5 1 1 CTX-M-14,TEM-1
ECL-10 8 16 >256 >256 >256 >256 >256 256 16 >64 >64 4 CTX-M-14, TEM-1,SHV-12
T-ECL10 8 8 >256 128 128 256 256 256 <0.125 <0.125 1 1 –
ECL-18 4 32 256 >256 256 256 >256 256 0.5 1 >64 2 IMP-4,TEM-1
T-ECL18 4 8 >256 128 16 256 256 256 <0.125 <0.125 >64 1 TEM-1
ECL-19 8 8 >256 >256 >256 >256 >256 256 16 64 >64 2 CTX-M-14,KPC-2
T-ECL19 8 4 >256 128 64 256 256 256 <0.125 <0.125 1 1 –
ECL-22 8 4 >256 >256 >256 >256 >256 256 32 32 >64 4 CTX-M-14, TEM-1,SHV-12
T-ECL22 8 8 >256 128 128 >256 256 256 0.25 0.5 1 1 TEM-1,SHV-12
ECL-27 4 4 256 >256 256 >256 >256 128 0.5 2 0.5 2 CTX-M-3, CTX-M-14, TEM-1,SHV-12
T-ECL27 8 8 >256 128 128 >256 256 256 <0.125 0.5 1 1 TEM-1
ECL-28 4 4 >256 >256 256 >256 >256 256 64 >64 4 4 TEM-1,SHV-12
T-ECL28 4 8 >256 >256 256 >256 256 256 0.25 1 2 1 TEM-1,SHV-12
KP-04 8 16 >256 >256 >256 >256 >256 128 2 4 1 2 CTX-M-14, VIM-1,TEM-1,SHV-12
T-KP04 8 16 >256 >256 >256 >256 >256 128 <0.125 0.5 1 1 SHV-12
KP-14 16 16 256 >256 >256 >256 >256 128 0.15 0.5 1 2 CTX-M-14, KPC-2,SHV-12
T-KP14 16 16 256 >256 >256 >256 >256 128 0.15 0.5 1 2 SHV-12
MM-23 8 4 128 >256 2 256 >256 >256 1 4 4 2 –
T-MM23 4 4 >256 128 1 >256 256 256 2 4 1 2 –
MM-26 8 4 64 >256 2 64 >256 >256 16 16 4 4 –
T-MM26 4 8 >256 128 1 >256 256 128 1 2 1 2 –
T denotes transconjugant. IPM, imipenem; MEM, meropenem; CAZ, ceftazidime; CTX, cefotaxime; ATM, aztreonam; TZP, piperacillin-tazobactam; CPS, cefoperazone/sulbactam; AMC,
amoxicillin-clavulanic acid; LEV, levofloxacin, FOS, fosfomycin; AK, amikacin; TIG, tigecycline.
cases, organisms belonging to the ST93 type were linked to two
cases of infections, and two new ST types, ST66 and ST190
were responsible for one infection each. Since the five ST114
isolates were collected from different wards at the Second People’s
Hospital of Jiaxing, we speculated that NDM-1-producing E.
cloacae strain ST114 may have already spread in the hospital.
In the United Kingdom and the Indian subcontinent,
blaNDM−1 has been found to be located in plasmids of various
sizes (ca. 50–300 kb), which generally belong to at least four
different Inc groups, including A/C,L/M, FI/FII and an undefined
type (Kumarasamy et al., 2010; Poirel et al., 2011). In our study,
most of blaNDM−1 elements recoverable from CRE isolates were
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harbored by self-transmissible plasmids, which also encoded
multiple β-lactamases and other determinants of amikacin and
fosfomycin resistance. This finding is consistent with currently
available data in China and various other countries. Finally,
our finding that transmission of conjugative plasmids encoding
various carbapenemases and clonal spread of strains containing
such plasmids were both responsible for a significant increase in
the number of NDM-1 positive CRE infections in a hospital in
China raised an alarming possibility that the prevalence of CRE
can increase rapidly in a hospital setting within a short period.
Whether the rate of infections due to such strains increases at a
similar rate in the future depends on numerous factors including
the effectiveness of infection control measures of the hospital
concerned and the immune status of the infected patients. More
works are urgently needed to investigate factors that determine
the rate of transmission of CRE and the mobile resistance
elements in order to help design appropriate intervention
strategies that pinpoint the core of the problem, that is, to target
the pool of existing CRE and the resistance elements that they
harbor.
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